(−)‐Epigallocatechin Gallate Ameliorates Chronic Stress‐Induced Depression‐Like Behavior in Rats by Inhibiting the NF‐κB/Caspase‐1 Signaling Pathway and Reducing IL‐1β and IL‐18 Expression. The gene discussed is IL1B; the disease is depressive symptom measurement.